Gerresheimer company profile

GXI · Xetra · EUR

Compare Gerresheimer
€31.56Change from previous close: −4.36%Absolute change: −€1.44

Close · November 20, 2026

Company profile

Gerresheimer has 13,301 employees and is headquartered in Düsseldorf, Germany.

Serving customers in Germany and internationally, Gerresheimer AG and its subsidiaries supply drug containment solutions across three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. Its range covers prefillable syringes, vials, glass cartridges and ampoules, plastic and glass packaging, and drug delivery devices such as inhalers and auto injectors, alongside diagnostic and medical products including point-of-care tests, lancing devices and infusion sets. Its customers include companies in pharma, biotech, medical technology, diagnostics, cosmetics, and food and beverage, as well as pharmacy chains, supermarkets and wholesalers.

In the fiscal year ended 30 November 2025, revenue reached EUR 2.3 billion, up 16.6% from the previous year, while the company posted a net loss of EUR 320.3 million. Gerresheimer had 13,301 employees and is headquartered in Düsseldorf, Germany, where it was founded in 1864.

Company facts

Sector
Materials
Industry
Medical Instruments & Supplies
Country
Germany
Headquarters
Peter-Müller-Straße 3, 40468, Düsseldorf
Employees
13,301
Chief executive
Uwe Röehrhoff
Founded
1864
Fiscal year
December - November
Listing
GXI · Xetra
Currency
EUR
ISIN
DE000A0LD6E6

Gerresheimer and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
GerresheimerGXIGermany$1.19B13,3011.6%—
Safilo GroupSFLItaly$972.72M3,3687.2%19.1
Bonesupport HoldingBONEXSweden$2.03B17425.5%78.1
AddLifeALIF.BSweden$2.11B2,4288.9%33.5
OttobockOBCKGermany$2.68B9,45518.7%19.0
Carl Zeiss MeditecAFXGermany$3.07B5,7847.2%23.3

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Gerresheimer with its competitors